644 related articles for article (PubMed ID: 32445412)
1. Efficacy of levetiracetam in the treatment of Sydenham chorea.
Direk M; Epcacan S; Epcacan Z; Yildirim DD; Okuyaz C
Pediatr Int; 2020 Nov; 62(11):1264-1268. PubMed ID: 32445412
[TBL] [Abstract][Full Text] [Related]
2. The use of haloperidol and valproate in children with Sydenham chorea.
Ronchezel MV; Hilario MO; Forleo LH; Len CA; Terreri MT; Vilanova LC; Sole D
Indian Pediatr; 1998 Dec; 35(12):1215-8. PubMed ID: 10216698
[No Abstract] [Full Text] [Related]
3. Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients.
Peña J; Mora E; Cardozo J; Molina O; Montiel C
Arq Neuropsiquiatr; 2002 Jun; 60(2-B):374-7. PubMed ID: 12131934
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid in the treatment of Sydenham chorea.
Alvarez LA; Novak G
Pediatr Neurol; 1985; 1(5):317-9. PubMed ID: 3939747
[TBL] [Abstract][Full Text] [Related]
5. Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens.
Genel F; Arslanoglu S; Uran N; Saylan B
Brain Dev; 2002 Mar; 24(2):73-6. PubMed ID: 11891095
[TBL] [Abstract][Full Text] [Related]
6. Effects on executive functions of antiepileptic monotherapy in pediatric age.
Operto FF; Pastorino GMG; Mazza R; Carotenuto M; Roccella M; Marotta R; di Bonaventura C; Verrotti A
Epilepsy Behav; 2020 Jan; 102():106648. PubMed ID: 31715510
[TBL] [Abstract][Full Text] [Related]
7. [Exceptionally good response to sodium valproate in patients with recurrent Sydenham's chorea].
Bouchal S; Ouali O; Belahsen MF
Pan Afr Med J; 2017; 27():212. PubMed ID: 28979614
[TBL] [Abstract][Full Text] [Related]
8. Treatments and Outcomes Among Patients with Sydenham Chorea: A Meta-Analysis.
Eyre M; Thomas T; Ferrarin E; Khamis S; Zuberi SM; Sie A; Newlove-Delgado T; Morton M; Molteni E; Dale RC; Lim M; Nosadini M;
JAMA Netw Open; 2024 Apr; 7(4):e246792. PubMed ID: 38625703
[TBL] [Abstract][Full Text] [Related]
9. [The efficiency of carbamazepine in a case of post-streptococcal hemichorea].
Hernández-Latorre MA; Roig-Quilis M
Rev Neurol; 2003 Aug 16-31; 37(4):322-6. PubMed ID: 14533107
[TBL] [Abstract][Full Text] [Related]
10. A New Alternative Drug With Fewer Adverse Effects in the Treatment of Sydenham Chorea: Levetiracetam Efficacy in a Child.
Şahin S; Cansu A
Clin Neuropharmacol; 2015; 38(4):144-6. PubMed ID: 26166232
[TBL] [Abstract][Full Text] [Related]
11. Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
Yu L; Feng J; Yu Z; Dai H
Epilepsy Res; 2020 Nov; 167():106448. PubMed ID: 32916644
[TBL] [Abstract][Full Text] [Related]
12. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
13. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
[TBL] [Abstract][Full Text] [Related]
14. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.
Fountain NB; Conry JA; Rodríguez-Leyva I; Gutierrez-Moctezuma J; Salas E; Coupez R; Stockis A; Lu ZS
Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of rheumatic chorea with carbamazepine.
Harel L; Zecharia A; Straussberg R; Volovitz B; Amir J
Pediatr Neurol; 2000 Aug; 23(2):147-51. PubMed ID: 11020640
[TBL] [Abstract][Full Text] [Related]
16. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
[TBL] [Abstract][Full Text] [Related]
17. Preliminary data on prednisone effectiveness in children with Sydenham chorea.
Favaretto E; Gortani G; Simonini G; Pastore S; Di Mascio A; Cimaz R; Taddio A
Eur J Pediatr; 2020 Jun; 179(6):993-997. PubMed ID: 31965299
[TBL] [Abstract][Full Text] [Related]
18. Change in Apo B100/A1 Ratio in Children With Epilepsy on Monotherapy With Sodium Valproate, Oxcarbazepine or Levetiracetam.
Lekhwani S; Dhama A; Kaushik JS
Indian Pediatr; 2023 Jun; 60(6):492-495. PubMed ID: 37293912
[TBL] [Abstract][Full Text] [Related]
19. Clinical Evaluation of Levetiracetam in the Treatment of Epilepsy.
Wu H; Liu J; Qian F; Yang J; Wang Y; Guan S
J Healthc Eng; 2022; 2022():3789516. PubMed ID: 35422974
[TBL] [Abstract][Full Text] [Related]
20. Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.
Lu PL; Hodes JF; Zheng X; Hu XY
Intern Med; 2020 Oct; 59(20):2471-2480. PubMed ID: 32611957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
